title: Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers.
abstract: Mutations in the BRCA1 gene result in an elevated risk of breast cancer (BC) and ovarian cancer (OC). However, risk estimates vary depending on the study population and statistical methodology used, and there are indications that the birth cohort and location of the mutation influence cancer risk. We investigated the risks for BC and OC associated with BRCA1 mutations in a young cohort of female mutation carriers who were identified by molecular genetic testing and belonged to a genetically heterogeneous Central European population. The study included 106 healthy and 158 affected carriers identified at an Austrian risk evaluation center. Risk estimation employed the product limit method. The log rank test was used to compare different strata. The risk of developing cancer to age 70 was found to be 85% for BC (95% CI 75-97%) and 53% for OC (95% CI 37-68%). Female mutation carriers born in 1958 or later were subject to a significantly higher risk of BC (P=0.005; 27% vs. 46% to age 40) and OC (P=0.006; 2% vs. 8% to age 40) than those born earlier. Mutations in exon 11 were associated with lower BC risk than mutations in exons 1-10 (P=0.008) and exons 12-24 (P=0.0006). OC risk was not influenced by mutation location (P=0.86). We conclude that female BRCA1 mutation carriers should be counseled about their cohort-dependent cancer risk. Further research into variables that affect cancer risk and are amenable to modification (e.g., lifestyle-related factors) should be considered a priority.
authors.affiliation: Division of Senology, Medical University of Vienna, Vienna, Austria. regina.kroiss@meduniwien.ac.at
authors.forename: Regina
authors.initials: R
authors.lastname: Kroiss
authors.forename: Verena
authors.initials: V
authors.lastname: Winkler
authors.forename: Diana
authors.initials: D
authors.lastname: Bikas
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Fleischmann
authors.forename: Claudia
authors.initials: C
authors.lastname: Mainau
authors.forename: Florian
authors.initials: F
authors.lastname: Frommlet
authors.forename: Daniela
authors.initials: D
authors.lastname: Muhr
authors.forename: Christine
authors.initials: C
authors.lastname: Fuerhauser
authors.forename: Maria
authors.initials: M
authors.lastname: Tea
authors.forename: Barbara
authors.initials: B
authors.lastname: Bittner
authors.forename: Ernst
authors.initials: E
authors.lastname: Kubista
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Oefner
authors.forename: Peter
authors.initials: P
authors.lastname: Bauer
authors.forename: Teresa M U
authors.initials: TM
authors.lastname: Wagner
mesh_terms: D000328:Adult; D000367:Age Factors; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics*; D015331:Cohort Studies; D005060:Europe / Q000453:epidemiology; D005260:Female; D019398:Genes, BRCA1; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics*; D012307:Risk Factors